Hostname: page-component-cd9895bd7-q99xh Total loading time: 0 Render date: 2024-12-22T08:01:51.428Z Has data issue: false hasContentIssue false
  • English
  • Français

Lack of effect of supplementation with essential fatty acids on bone mineral density in healthy pre- and postmenopausal women:two randomized controlled trials of Efacal® v. calcium alone

Published online by Cambridge University Press:  09 March 2007

E. Joan Bassey ,
Julie J. Littlewood ,
M. Claire Rothwell  and
David W. Pye
E. Joan Bassey*
Affiliation:
University of Nottingham Medical School, Nottingham NG7 2UH, UK
Julie J. Littlewood
Affiliation:
University of Nottingham Medical School, Nottingham NG7 2UH, UK
M. Claire Rothwell
Affiliation:
University of Nottingham Medical School, Nottingham NG7 2UH, UK
David W. Pye
Affiliation:
University of Nottingham Medical School, Nottingham NG7 2UH, UK
*
*Corresponding author: Dr E. Joan Bassey, fax +44 (0)1159 709259, email [email protected]
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Randomized controlled trials of the effects of the dietary supplement Efacal® (Scotia Pharmaceuticals Plc, Guildford, Surrey, UK) v. Ca only on total body bone mineral density (BMD) and markers of bone turnover were conducted in healthy pre- and postmenopausal women separately. Total daily dose for 12 months for the Efacal® groups was: Ca 1·0 g, evening primrose oil 4·0 g and marine fish oil 440 mg; and for the control groups was: Ca 1·0 g. Reported compliance was better than 90 % in both age groups. For the forty-three premenopausal women (age range 25–40 years), initial mean total body BMD values were similar for Efacal® and control groups and both groups showed highly significant mean increases of about 1 %; however, there were no significant between-group differences for the changes in BMD or markers of bone turnover. For the forty-two postmenopausal women (age range 50–65 years), initial mean total body BMD values were again well-matched across treatment groups. Both Efacal® and control groups showed highly significant decreases in total body BMD of about 1 %, but again there were no significant between-group differences in total body BMD or markers of bone turnover. Possible confounding variables such as initial total body BMD were explored but had no effect on the outcome in either age group. Nail quality improved in both age groups and in both Efacal® and control groups. Again, there was no significant difference between treatment groups. No evidence was found to support a beneficial effect of Efacal® on BMD in these women.

Keywords

Bone mineral densityMenopauseEssential fatty acids
Type
Research Article
Information
British Journal of Nutrition , Volume 83 , Issue 6 , June 2000 , pp. 629 - 635
Copyright
Copyright © The Nutrition Society 2000

References

Allied Dunbar National Fitness Survey (1992) Main findings: A Report on Activity Patterns and Fitness Levels. London: Sports Council and Health Education Authority.Google Scholar
Coetzer, HClaasen, NVan Papendorf, D and Kruger, M (1994) Calcium transport by isolated brush border and basolateral membrane vesicles: role of essential fatty acid supplementation Prostaglandins Leukotrienes and Essential Fatty Acids 50, 257–266.CrossRefGoogle ScholarPubMed
Department of Health (1991) Dietary Values for Food Energy and Nutrients for the UK. Report on Health and Social Subjects no. 41. London: H.M. Stationery Office.Google Scholar
Gore, SM & Altman, DG (1988) Statistics in Practice, pp. 6–8. London: BMA.Google Scholar
Hay, AHassam, ACrawford, M, Stevens, PMawer, E and Sutherland Jones, F (1980) Essential fatty acids restriction inhibits vitamin D dependant calcium absorption Lipids 15, 251–254.CrossRefGoogle ScholarPubMed
Healy, MJR (1958) Variations within individuals in human biology Human Biology 30, 210–218.Google ScholarPubMed
Horrobin, DF (1992) Nutritional and medical importance of gamma-linolenic acid Progress in Lipid Research 31, 163–194.CrossRefGoogle ScholarPubMed
Kruger, MPotgeiter, H de Winter, RCoetzer, H and Van Papendorf, D (1996) Calcium, gamma-linolenic acid and eicosapentanoic acid supplementation in osteoporosis Osteoporosis International 6(Suppl. 1), 250.CrossRefGoogle Scholar
Littlewood, JJ (1998) Effects of dietary supplementation with Efacal, on total body bone mineral density in pre- and postmenopausal women. M Phil Thesis, University of Nottingham.Google Scholar
Morse, PHorrobin, DFManku, MS, Stewart, JCAllen, RLittlewood, S, Wright, SBurton, J, Gould, DJ and Holt, PJ (1989) Meta-analysis of placebo-controlled studies of the efficacy of Epogam in the treatment of atopic eczema. Relationship between plasma essential fatty acid changes and clinical response British Journal of Dermatology 121, 75–90.CrossRefGoogle ScholarPubMed
Norrdin, RWJee, WSS and High, WB (1990) The role of prostaglandins in bone in vivo Prostaglandins Leukotrienes and Essential Fatty Acids 41, 139–149.CrossRefGoogle ScholarPubMed
Pye, DJ, Bassey, EJ & Armstrong, A (1992) Precision in practice — experience with a Lunar DPX-L densitometer. In Current Research in Osteoporosis & Bone Mineral Measurement II, chapter 2, p. 21 [Ring, EFJ, editor], London: The British Institute of Radiology.Google Scholar
Ramsdale, SJ (1995) Bone mineral density in women: effects of exercise and changes in body mass. PhD Thesis, University of Nottingham.Google Scholar
Ramsdale, SJBassey, EJ and Pye, DW (1994) Dietary calcium intake relates to bone mineral density in premenopausal women British Journal of Nutrition 71, 77–84.CrossRefGoogle ScholarPubMed
Van Papendorp, DHCoetzer, H and Kruger, MC (1995) Biochemical profile of osteoporotic patients on essential fatty acid supplementation Nutrition Research 15, 325–334.CrossRefGoogle Scholar
Welten, D, Kemper, HPost, G and Van Staveren, W (1995) A meta-analysis of the effect of calcium intake in bone mass in young and middle-aged females Journal of Nutrition 125, 2802–2813.Google Scholar